Science Speaks is at IDWeek in San Diego, California this week, bringing live coverage of sessions on HIV, TB, Ebola and more. SAN DIEGO, Calif – Despite steady progress made against the HIV pandemic over the past decade, only one third of people living with HIV are on antiretroviral therapy, leaving over 23 million people in need […]
Science Speaks is at IDWeek in San Diego, California this week, bringing live coverage of sessions on HIV, TB, Ebola and more. SAN DIEGO, Calif. – After the HPTN 052 trial settled the question of whether early HIV treatment prevents transmission of the virus, the START trial settled the question of the value of treatment for individual health, Dr. Myron Cohen […]
HIV
The following is a guest post by Mitchell Warren of AVAC This year’s annual HIV Vaccine Awareness Day arrives Saturday at a promising and also perilous […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]